Centiva Capital’s Terns Pharmaceuticals TERN Stock Holding History

Centiva Capital’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-100,700	Closed	-$5.31M	–	2199
2026 Q1	$5.31M	Buy	+100,700	New	+$4.14M	0.04%	266

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Centiva Capital's TERN Position: Q2 2026 in Review

Centiva Capital sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 101,225 shares — an estimated $5.34M sold.

Centiva Capital first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $5.34M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Centiva Capital reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Centiva Capital sold 101,225 Terns Pharmaceuticals shares in Q2 2026, an estimated $5.34M.
Centiva Capital first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Centiva Capital's Terns Pharmaceuticals position peaked at $5.34M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.